These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25138222)

  • 1. Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.
    Heinicke T; Hütten H; Kalinski T; Franke I; Bonnekoh B; Fischer T
    Ann Hematol; 2015 Feb; 94(2):283-7. PubMed ID: 25138222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
    Sakashita K; Saito S; Yanagisawa R; Tanaka M; Yoshikawa K; Hirabayashi K; Tsukahara K; Motobayashi M; Nakazawa Y; Koike K
    Pediatr Blood Cancer; 2013 Nov; 60(11):E140-2. PubMed ID: 23788509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Very Rare Type of Leukemia in a Young Pediatric Patient Treated With Hematopoietic Stem Cell Transplantation: Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Tekkeşin F; Asarcikli F; Yildirim ÜM; Zemheri IE; Kiliç SÇ
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e288-e291. PubMed ID: 33235146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.
    Dietrich S; Andrulis M; Hegenbart U; Schmitt T; Bellos F; Martens UM; Meissner J; Krämer A; Ho AD; Dreger P
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1250-4. PubMed ID: 21215813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.
    Falcone U; Sibai H; Deotare U
    Crit Rev Oncol Hematol; 2016 Nov; 107():156-162. PubMed ID: 27823644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiotepa-busulfan-fludarabine-based conditioning as a promising approach prior to allogeneic hematopoietic stem cell transplantation in patients with blastic plasmacytoid dendritic cell neoplasm.
    Huang X; Wang S; Xu Y; Mei C; Han Q; Wu X; Du F; Ren Y; Jin J; Tong H; Qian J
    Ann Hematol; 2024 Jun; 103(6):2165-2168. PubMed ID: 38584216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.
    Kim HS; Kim HJ; Kim SH; Choi JY; Ko YH; Kim WS; Jung CW; Kim SJ
    Korean J Intern Med; 2017 Sep; 32(5):890-899. PubMed ID: 28870016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood blastic plasmacytoid dendritic cell neoplasm treated with allogenic stem cell transplantation.
    Gambichler T; Pantelaki I; Stücker M
    Pediatr Dermatol; 2013; 30(1):142-4. PubMed ID: 22300352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
    Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
    Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastic plasmacytoid dendritic cell neoplasm.
    Lim D; Goodman H; Rademaker M; Lamont D; Yung A
    Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease.
    Deotare U; Kim DD; Michelis FV; Lipton JH
    Leuk Lymphoma; 2016 Aug; 57(8):1942-4. PubMed ID: 26699933
    [No Abstract]   [Full Text] [Related]  

  • 13. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
    An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
    Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.
    Roos-Weil D; Dietrich S; Boumendil A; Polge E; Bron D; Carreras E; Iriondo Atienza A; Arcese W; Beelen DW; Cornelissen JJ; Kröger N; Milone G; Rossi G; Jardin F; Peters C; Rocha V; Sureda A; Mohty M; Dreger P;
    Blood; 2013 Jan; 121(3):440-6. PubMed ID: 23203822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic.
    Cernan M; Szotkowski T; Hisemova M; Cetkovsky P; Sramkova L; Stary J; Racil Z; Mayer J; Sramek J; Jindra P; Visek B; Zak P; Novak J; Kozak T; Furst T; Papajik T
    Neoplasma; 2020 May; 67(3):650-659. PubMed ID: 32064883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
    Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
    Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.
    Male HJ; Davis MB; McGuirk JP; Abhyankar S; Aljitawi OS; Zhang D; Ganguly S
    Int J Hematol; 2010 Sep; 92(2):398-400. PubMed ID: 20697854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.